Effect of pravastatin on erythrocyte membrane fatty acid contents in patients with chronic kidney disease

Effect of pravastatin on erythrocyte membrane fatty acid contents in patients with chronic kidney disease

Background Statin treatment has decreased the risk of cardiovascular events in patients with chronic kidney disease (CKD). Erythrocyte membrane oleic acid level is higher in patients with acute coronary syndrome. This study aimed to evaluate the effect of pravastatin on the erythrocyte membrane fatt...

Full description

Bibliographic Details
Main Authors:	Su Mi Lee, Young Ki Son, Seong Eun Kim, Yeong Hoon Kim, Yongsoon Park, Won Suk An
Format:	Article
Language:	English
Published:	The Korean Society of Nephrology 2021-09-01
Series:	Kidney Research and Clinical Practice
Subjects:	chronic kidney disease omega-3 fatty acid pravastatin
Online Access:	http://www.krcp-ksn.org/upload/pdf/j-krcp-20-247.pdf

Similar Items

Impact of Blood or Erythrocyte Membrane Fatty Acids for Disease Risk Prediction: Focusing on Cardiovascular Disease and Chronic Kidney Disease
by: Oh Yoen Kim, et al.
Published: (2018-10-01)

Pravastatin Alleviates Radiation Proctitis by Regulating Thrombomodulin in Irradiated Endothelial Cells
by: Hyosun Jang, et al.
Published: (2020-03-01)

Omega-3 fatty acid decreases oleic acid by decreasing SCD-1 expression in the liver and kidney of a cyclosporine-induced nephropathy rat model
by: Su Mi Lee, et al.
Published: (2019-01-01)

Effect of Omega-3 Fatty Acid on STAMP2 Expression in the Heart and Kidney of 5/6 Nephrectomy Rat Model
by: Hye Won Lee, et al.
Published: (2018-10-01)

Different Effects of Pravastatin on Preeclampsia-like Symptoms in Different Mouse Models
by: Jing Huai, et al.
Published: (2018-01-01)

Pravastatin inhibits cell proliferation and increased MAT1A expression in hepatocarcinoma cells and in vivo models
by: Hijona Elizabeth, et al.
Published: (2012-02-01)

Simvastatin-induced nocturnal leg pain disappears with pravastatin substitution
by: Stojaković Nataša, et al.
Published: (2013-01-01)

A Prospective Study of Pravastatin in the Elderly at Risk (PROSPER): Screening Experience and Baseline Characteristics
by: Lagaay A Margot, et al.
Published: (2002-05-01)

Pravastatin Attenuates Acute Radiation-Induced Enteropathy and Improves Epithelial Cell Function
by: Hyosun Jang, et al.
Published: (2018-10-01)

High-performance liquid chromatography and derivative spectrophotometry for simultaneous determination of pravastatin and fenofibrate in the dosage form
by: Hefnawy Mohamed M., et al.
Published: (2014-12-01)

Pravastatin and Gemfibrozil Modulate Differently Hepatic and Colonic Mitochondrial Respiration in Tissue Homogenates from Healthy Rats
by: Anna Herminghaus, et al.
Published: (2019-08-01)

Effect of pravastatin treatment on circulating adiponectin: a meta-analysis of randomized controlled trials
by: Shu X, et al.
Published: (2019-05-01)

Pravastatin induces NO synthesis by enhancing microsomal arginine uptake in healthy and preeclamptic placentas
by: Zita Pánczél, et al.
Published: (2019-11-01)

Pilot randomized trial of short-term changes in inflammation and lipid levels during and after aspirin and pravastatin therapy
by: Kerry S. Flannagan, et al.
Published: (2019-09-01)

Therapeutic potential of pravastatin for random skin flaps necrosis: involvement of promoting angiogenesis and inhibiting apoptosis and oxidative stress
by: Lin J, et al.
Published: (2019-05-01)

Pravastatin Protects Against Avascular Necrosis of Femoral Head via Autophagy
by: Yun Liao, et al.
Published: (2018-04-01)

Overweight and erythrocyte polyunsaturated fatty acid changes in menopause
by: D’Alberti Giulia, et al.
Published: (2020-07-01)

PRAVASTATIN IN CORRECTION OF VESSEL WALL ANTIPLATELET CONTROL OVER THE BLOOD CELLS IN PATIENTS WITH ARTERIAL HYPERTENSION AND DYSLIPIDEMIA
by: I. N. Medvedev, et al.
Published: (2014-12-01)

Efficacy and Safety of the Combination of Pravastatin and Sorafenib for the Treatment of Advanced Hepatocellular Carcinoma (ESTAHEP Clinical Trial)
by: Ioana Riaño, et al.
Published: (2020-07-01)

Formulation, in vitro release and transdermal diffusion of pravastatin by the implementation of the delivery gap principle / Cornel Burger
by: Burger, Cornel
Published: (2015)

Formulation, in vitro release and transdermal diffusion of pravastatin by the implementation of the delivery gap principle / Cornel Burger
by: Burger, Cornel
Published: (2015)

Pravastatin alleviates intracellular calcium dysregulation induced by Interleukin-6 via the mitochondrial ROS pathway in adult ventricular myocytes
by: Song Zuo, et al.
Published: (2020-07-01)

The Effects of Omega-3 Fatty Acid on Vitamin D Activation in Hemodialysis Patients: A Pilot Study
by: Su Mi Lee, et al.
Published: (2015-01-01)

Pravastatin Prevents Aortic Atherosclerosis via Modulation of Signal Transduction and Activation of Transcription 3 (STAT3) to Attenuate Interleukin-6 (IL-6) Action in ApoE Knockout Mice
by: Xiaoxu Zhou, et al.
Published: (2008-11-01)

Protective Effect of Pravastatin on Myocardial Ischemia Reperfusion Injury by Regulation of the miR-93/Nrf2/ARE Signal Pathway
by: Liu Z, et al.
Published: (2020-09-01)

Statins not effective in reducing osteoporotic fractures
by: Lyford Joanna, et al.
Published: (2001-03-01)

Pravastatin Promotes Endothelial Colony-Forming Cell Function, Angiogenic Signaling and Protein Expression In Vitro
by: Nadia Meyer, et al.
Published: (2021-01-01)

Coenzyme Q10 or Creatine Counteract Pravastatin-Induced Liver Redox Changes in Hypercholesterolemic Mice
by: Ana C. Marques, et al.
Published: (2018-06-01)

Therapeutic Effects of Omega-3 Fatty Acids on Chronic Kidney Disease-Associated Pruritus: a Literature Review
by: Yunes Panahi, et al.
Published: (2016-12-01)

Omega-3 fatty acid supplementation as an adjunctive therapy in the treatment of chronic kidney disease: a meta-analysis
by: Jing Hu, et al.

Pravastatin induces cell cycle arrest and decreased production of VEGF and bFGF in multiple myeloma cell line
by: P. J. J. Trojan, et al.

Efficacy, safety and tolerability of ongoing statin plus ezetimibe versus doubling the ongoing statin dose in hypercholesterolemic Taiwanese patients: an open-label, randomized clinical trial
by: Yu Chih-Chieh, et al.
Published: (2012-05-01)

Green leafy vegetables in diets with a 25:1 omega-6/omega-3 fatty acid ratio modify the erythrocyte fatty acid profile of spontaneously hypertensive rats
by: Melissa Johnson, et al.
Published: (2018-06-01)

Effect of Dietary Omega-3 and Omega-6 Polyunsaturated Fatty Acids on Alcoholic Liver Disease
by: Purwaha, Preeti
Published: (2017)

Fatty Acids and Cardiovascular Risk. Evidence, Lack of Evidence, and Diligence
by: Francesco Visioli, et al.
Published: (2020-12-01)

Blood Omega-3 Fatty Acids Are Inversely Associated With Albumin-Creatinine Ratio in Young and Healthy Adults (The Omega-Kid Study)
by: Mark G. Filipovic, et al.
Published: (2021-04-01)

The Role of Statins in Prevention of Preeclampsia: A Promise for the Future?
by: Vasiliki Katsi, et al.
Published: (2017-05-01)

The effect of omega-3 fatty acid supplementation on clinical and biochemical parameters of critically ill patients with COVID-19: a randomized clinical trial
by: Saeid Doaei, et al.
Published: (2021-03-01)

Restoration of dietary-fat induced blood–brain barrier dysfunction by anti-inflammatory lipid-modulating agents
by: Pallebage-Gamarallage Menuka, et al.
Published: (2012-09-01)

Defective Mitochondrial Fatty Acid Oxidation and Lipotoxicity in Kidney Diseases
by: Hee-Seong Jang, et al.
Published: (2020-03-01)